Novavax Inc <a href="https://www.reuters.com/companies/NVAX.O" target="_blank">(NVAX.O)</a> said on Wednesday it will manufacture its COVID-19 vaccine in Canada after the country's health regulator allowed its use in children aged between 12 and 17 years as a…